SEATTLE--(BUSINESS WIRE)--Dec. 2, 2005--Sonus Pharmaceuticals, Inc. (NASDAQ:SNUS) today announced the scheduled presentation of a poster on TOCOSOL(R) Paclitaxel at the upcoming San Antonio Breast Cancer Symposium, to be held in San Antonio, Texas from December 8-11. The poster presentation will include efficacy data from an ongoing Phase 2 trial in metastatic breast cancer as well as an update on the safety and tolerability of TOCOSOL Paclitaxel for all patients treated to date in the Phase 2 program.
